A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis
for Myasthenia Gravis
Drug: Nipocalimab
11 locations incl. Phoenix
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 2 - 17
Code: NCT05265273·Phase 2, Phase 3·Recruiting